199 related articles for article (PubMed ID: 18375924)
1. Imaging of VEGF receptor in a rat myocardial infarction model using PET.
Rodriguez-Porcel M; Cai W; Gheysens O; Willmann JK; Chen K; Wang H; Chen IY; He L; Wu JC; Li ZB; Mohamedali KA; Kim S; Rosenblum MG; Chen X; Gambhir SS
J Nucl Med; 2008 Apr; 49(4):667-73. PubMed ID: 18375924
[TBL] [Abstract][Full Text] [Related]
2. 64Cu-DOTA as a surrogate positron analog of Gd-DOTA for cardiac fibrosis detection with PET: pharmacokinetic study in a rat model of chronic MI.
Kim H; Lee SJ; Davies-Venn C; Kim JS; Yang BY; Yao Z; Kim I; Paik CH; Bluemke DA
Nucl Med Commun; 2016 Feb; 37(2):188-96. PubMed ID: 26488428
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography imaging of poststroke angiogenesis.
Cai W; Guzman R; Hsu AR; Wang H; Chen K; Sun G; Gera A; Choi R; Bliss T; He L; Li ZB; Maag AL; Hori N; Zhao H; Moseley M; Steinberg GK; Chen X
Stroke; 2009 Jan; 40(1):270-7. PubMed ID: 18948613
[TBL] [Abstract][Full Text] [Related]
4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography.
Willmann JK; Chen K; Wang H; Paulmurugan R; Rollins M; Cai W; Wang DS; Chen IY; Gheysens O; Rodriguez-Porcel M; Chen X; Gambhir SS
Circulation; 2008 Feb; 117(7):915-22. PubMed ID: 18250264
[TBL] [Abstract][Full Text] [Related]
7.
Autio A; Uotila S; Kiugel M; Kytö V; Liljenbäck H; Kudomi N; Oikonen V; Metsälä O; Helin S; Knuuti J; Saraste A; Roivainen A
J Nucl Cardiol; 2020 Jun; 27(3):891-898. PubMed ID: 31144229
[TBL] [Abstract][Full Text] [Related]
8. PET of vascular endothelial growth factor receptor expression.
Cai W; Chen K; Mohamedali KA; Cao Q; Gambhir SS; Rosenblum MG; Chen X
J Nucl Med; 2006 Dec; 47(12):2048-56. PubMed ID: 17138749
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts.
Paudyal B; Paudyal P; Oriuchi N; Hanaoka H; Tominaga H; Endo K
Cancer Sci; 2011 Jan; 102(1):117-21. PubMed ID: 21070475
[TBL] [Abstract][Full Text] [Related]
10. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.
Hsu AR; Cai W; Veeravagu A; Mohamedali KA; Chen K; Kim S; Vogel H; Hou LC; Tse V; Rosenblum MG; Chen X
J Nucl Med; 2007 Mar; 48(3):445-54. PubMed ID: 17332623
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.
Zhang Y; Hong H; Niu G; Valdovinos HF; Orbay H; Nayak TR; Chen X; Barnhart TE; Cai W
Mol Pharm; 2012 Dec; 9(12):3586-94. PubMed ID: 23137334
[TBL] [Abstract][Full Text] [Related]
12. Dimeric [(68)Ga]DOTA-RGD peptide targeting αvβ 3 integrin reveals extracellular matrix alterations after myocardial infarction.
Kiugel M; Dijkgraaf I; Kytö V; Helin S; Liljenbäck H; Saanijoki T; Yim CB; Oikonen V; Saukko P; Knuuti J; Roivainen A; Saraste A
Mol Imaging Biol; 2014 Dec; 16(6):793-801. PubMed ID: 24984688
[TBL] [Abstract][Full Text] [Related]
13. Quantitative PET imaging of VEGF receptor expression.
Chen K; Cai W; Li ZB; Wang H; Chen X
Mol Imaging Biol; 2009; 11(1):15-22. PubMed ID: 18784964
[TBL] [Abstract][Full Text] [Related]
14. PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury.
Gao H; Kiesewetter DO; Zhang X; Huang X; Guo N; Lang L; Hida N; Wang H; Wang H; Cao F; Niu G; Chen X
J Nucl Med; 2012 Dec; 53(12):1960-8. PubMed ID: 23139087
[TBL] [Abstract][Full Text] [Related]
15. Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots.
Chen K; Li ZB; Wang H; Cai W; Chen X
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2235-44. PubMed ID: 18566815
[TBL] [Abstract][Full Text] [Related]
16. A vascular endothelial growth factor 121 (VEGF(121))-based dual PET/optical probe for in vivo imaging of VEGF receptor expression.
Kang CM; Koo HJ; Lee KC; Choe YS; Choi JY; Lee KH; Kim BT
Biomaterials; 2013 Sep; 34(28):6839-45. PubMed ID: 23787114
[TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a
Varasteh Z; Mohanta S; Robu S; Braeuer M; Li Y; Omidvari N; Topping G; Sun T; Nekolla SG; Richter A; Weber C; Habenicht A; Haberkorn UA; Weber WA
J Nucl Med; 2019 Dec; 60(12):1743-1749. PubMed ID: 31405922
[TBL] [Abstract][Full Text] [Related]
18. Targeting of endothelin receptors in the healthy and infarcted rat heart using the PET tracer 18F-FBzBMS.
Higuchi T; Rischpler C; Fukushima K; Isoda T; Xia J; Javadi MS; Szabo Z; Dannals RF; Mathews WB; Bengel FM
J Nucl Med; 2013 Feb; 54(2):277-82. PubMed ID: 23315664
[TBL] [Abstract][Full Text] [Related]
19. PET monitoring angiogenesis of infarcted myocardium after treatment with vascular endothelial growth factor and bone marrow mesenchymal stem cells.
Cai M; Ren L; Yin X; Guo Z; Li Y; He T; Tang Y; Long T; Liu Y; Liu G; Zhang X; Hu S
Amino Acids; 2016 Mar; 48(3):811-820. PubMed ID: 26592497
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]